Hinge Health initially aimed to sell nearly 14 million shares in a $28-$32 range, with final pricing set at the higher end of the range. With some 8.5 million shares sold by the business, gross process from the offering are pegged at $272 million.

Hinge Health, Inc. engages in the development of technology platform for the treatment of musculoskeletal (MSK) conditions. Its platform addresses a broad spectrum of MSK care, from acute injury to chronic pain and to post-surgical rehabilitation.

Stock futures traded slightly lower Friday and the S&P 500, down for three straight sessions, limped into the Memorial Day weekend.These stocks were poised to make moves Friday:Tesla rose 1.2% in premarket trading.

As Hinge Health goes public, CEO Dan Perez tells STAT the goal is to automate physical therapy in any way it can.

Deckers Outdoor (DECK) gave a lower-than-expected outlook for the current quarter, sending shares lower 13%. Ross Stores (ROSS) shares fell 11% afterhours following the

Initial public offerings from Hinge Health Inc. and MNTN Inc. both priced at the top of their estimated ranges in a bullish sign for the two deals, as the market for initial public offerings continues to gear up after an absence of deals in recent weeks.

The World Health Organization adopted a pandemic preparedness treaty, but the absence of the U.S. questions its efficacy. Texas reports a rise in measles cases, and digital health startup Hinge Health raises $437.